STAAR Surgical Company (STAA)
USD 24.26
(-4.64%)
USD 24.26
(-4.64%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 21.34 Million USD | -46.18% |
| 2022 | 39.66 Million USD | 44.18% |
| 2021 | 27.51 Million USD | 365.26% |
| 2020 | 5.91 Million USD | -57.91% |
| 2019 | 14.04 Million USD | 182.77% |
| 2018 | 4.96 Million USD | 332.26% |
| 2017 | -2.13 Million USD | 82.36% |
| 2016 | -12.12 Million USD | -85.66% |
| 2015 | -6.53 Million USD | 22.15% |
| 2014 | -8.39 Million USD | -2208.54% |
| 2013 | 398 Thousand USD | 122.58% |
| 2012 | -1.76 Million USD | -230.79% |
| 2011 | 1.34 Million USD | 2443.4% |
| 2010 | 53 Thousand USD | 100.85% |
| 2009 | -6.2 Million USD | 73.27% |
| 2008 | -23.19 Million USD | -44.98% |
| 2007 | -15.99 Million USD | -6.35% |
| 2006 | -15.04 Million USD | -34.62% |
| 2005 | -11.17 Million USD | 1.39% |
| 2004 | -11.33 Million USD | -35.6% |
| 2003 | -8.35 Million USD | 51.29% |
| 2002 | -17.15 Million USD | -15.67% |
| 2001 | -14.83 Million USD | 21.53% |
| 2000 | -18.9 Million USD | -959.16% |
| 1999 | 2.2 Million USD | -8.33% |
| 1998 | 2.4 Million USD | -67.57% |
| 1997 | 7.4 Million USD | 7.25% |
| 1996 | 6.9 Million USD | -8.0% |
| 1995 | 7.5 Million USD | -9.64% |
| 1994 | 8.3 Million USD | 232.0% |
| 1993 | 2.5 Million USD | 149.02% |
| 1992 | -5.1 Million USD | 54.87% |
| 1991 | -11.3 Million USD | -422.86% |
| 1990 | 3.5 Million USD | 179.55% |
| 1989 | -4.4 Million USD | -15.79% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.33 Million USD | -143.05% |
| 2024 Q2 | 7.37 Million USD | 320.99% |
| 2024 Q3 | 9.98 Million USD | 35.25% |
| 2023 Q3 | 4.81 Million USD | -20.56% |
| 2023 FY | 21.34 Million USD | -46.18% |
| 2023 Q4 | 7.75 Million USD | 61.01% |
| 2023 Q1 | 2.71 Million USD | -53.7% |
| 2023 Q2 | 6.06 Million USD | 123.76% |
| 2022 Q3 | 10.26 Million USD | -21.29% |
| 2022 FY | 39.66 Million USD | 44.18% |
| 2022 Q1 | 9.6 Million USD | 95.08% |
| 2022 Q2 | 13.03 Million USD | 35.78% |
| 2022 Q4 | 5.85 Million USD | -42.96% |
| 2021 Q1 | 4.99 Million USD | 50.05% |
| 2021 Q2 | 8.56 Million USD | 71.61% |
| 2021 FY | 27.51 Million USD | 365.26% |
| 2021 Q3 | 6.02 Million USD | -29.73% |
| 2021 Q4 | 4.92 Million USD | -18.24% |
| 2020 FY | 5.91 Million USD | -57.91% |
| 2020 Q2 | -1.17 Million USD | -774.63% |
| 2020 Q3 | 3.89 Million USD | 432.08% |
| 2020 Q4 | 3.32 Million USD | -14.52% |
| 2020 Q1 | -134 Thousand USD | -102.1% |
| 2019 Q2 | 3.91 Million USD | 186.32% |
| 2019 Q1 | 1.36 Million USD | 24.73% |
| 2019 FY | 14.04 Million USD | 182.77% |
| 2019 Q4 | 6.37 Million USD | 167.13% |
| 2019 Q3 | 2.38 Million USD | -38.99% |
| 2018 Q4 | 1.09 Million USD | -24.88% |
| 2018 Q2 | 1.83 Million USD | 213.89% |
| 2018 Q1 | 583 Thousand USD | 522.46% |
| 2018 FY | 4.96 Million USD | 332.26% |
| 2018 Q3 | 1.45 Million USD | -20.27% |
| 2017 FY | -2.13 Million USD | 82.36% |
| 2017 Q4 | -138 Thousand USD | -111.76% |
| 2017 Q3 | 1.17 Million USD | 220.8% |
| 2017 Q2 | -971 Thousand USD | 55.92% |
| 2017 Q1 | -2.2 Million USD | -1227.11% |
| 2016 Q4 | -166 Thousand USD | 90.66% |
| 2016 Q1 | -8.04 Million USD | -852.73% |
| 2016 Q2 | -2.14 Million USD | 73.35% |
| 2016 FY | -12.12 Million USD | -85.66% |
| 2016 Q3 | -1.77 Million USD | 17.03% |
| 2015 Q1 | -2.34 Million USD | 7.8% |
| 2015 Q3 | -1.75 Million USD | -9.57% |
| 2015 FY | -6.53 Million USD | 22.15% |
| 2015 Q4 | -844 Thousand USD | 51.83% |
| 2015 Q2 | -1.59 Million USD | 31.67% |
| 2014 Q3 | -2.7 Million USD | -51.26% |
| 2014 Q1 | -1.35 Million USD | -55.14% |
| 2014 Q2 | -1.78 Million USD | -31.64% |
| 2014 FY | -8.39 Million USD | -2208.54% |
| 2014 Q4 | -2.53 Million USD | 6.21% |
| 2013 Q4 | -876 Thousand USD | -266.86% |
| 2013 FY | 398 Thousand USD | 122.58% |
| 2013 Q1 | 471 Thousand USD | 133.31% |
| 2013 Q2 | 278 Thousand USD | -40.98% |
| 2013 Q3 | 525 Thousand USD | 88.85% |
| 2012 Q2 | -491 Thousand USD | -311.64% |
| 2012 Q1 | 232 Thousand USD | 112.84% |
| 2012 Q4 | -1.41 Million USD | -1471.11% |
| 2012 Q3 | -90 Thousand USD | 81.67% |
| 2012 FY | -1.76 Million USD | -230.79% |
| 2011 FY | 1.34 Million USD | 2443.4% |
| 2011 Q3 | 77 Thousand USD | -91.06% |
| 2011 Q2 | 861 Thousand USD | 187.0% |
| 2011 Q4 | 109 Thousand USD | 41.56% |
| 2011 Q1 | 300 Thousand USD | 143.42% |
| 2010 Q2 | -1.62 Million USD | -146.12% |
| 2010 FY | 53 Thousand USD | 100.85% |
| 2010 Q4 | -691 Thousand USD | 40.33% |
| 2010 Q3 | -1.15 Million USD | 28.87% |
| 2010 Q1 | 3.53 Million USD | 338.03% |
| 2009 Q1 | -1.66 Million USD | 82.43% |
| 2009 FY | -6.2 Million USD | 73.27% |
| 2009 Q4 | -1.48 Million USD | 24.61% |
| 2009 Q3 | -1.96 Million USD | -80.79% |
| 2009 Q2 | -1.08 Million USD | 34.54% |
| 2008 FY | -23.19 Million USD | -44.98% |
| 2008 Q1 | -8.94 Million USD | -108.34% |
| 2008 Q2 | -2.54 Million USD | 71.53% |
| 2008 Q3 | -2.25 Million USD | 11.59% |
| 2008 Q4 | -9.46 Million USD | -320.44% |
| 2007 FY | -15.99 Million USD | -6.35% |
| 2007 Q1 | -3.52 Million USD | 37.96% |
| 2007 Q2 | -4.35 Million USD | -23.74% |
| 2007 Q3 | -3.83 Million USD | 12.1% |
| 2007 Q4 | -4.29 Million USD | -12.04% |
| 2006 Q4 | -5.67 Million USD | -103.48% |
| 2006 FY | -15.04 Million USD | -34.62% |
| 2006 Q3 | -2.78 Million USD | 13.33% |
| 2006 Q1 | -3.36 Million USD | 1.84% |
| 2006 Q2 | -3.21 Million USD | 4.28% |
| 2005 Q4 | -3.42 Million USD | -3.73% |
| 2005 FY | -11.17 Million USD | 1.39% |
| 2005 Q2 | -2.11 Million USD | 9.75% |
| 2005 Q3 | -3.3 Million USD | -56.49% |
| 2005 Q1 | -2.33 Million USD | 46.67% |
| 2004 Q2 | -3.38 Million USD | -160.2% |
| 2004 Q4 | -4.38 Million USD | -93.3% |
| 2004 Q1 | -1.29 Million USD | 63.1% |
| 2004 FY | -11.33 Million USD | -35.6% |
| 2004 Q3 | -2.26 Million USD | 32.9% |
| 2003 Q2 | -1.11 Million USD | -49.4% |
| 2003 FY | -8.35 Million USD | 51.29% |
| 2003 Q1 | -747 Thousand USD | 92.61% |
| 2003 Q3 | -2.71 Million USD | -142.83% |
| 2003 Q4 | -3.52 Million USD | -29.89% |
| 2002 Q3 | -2.14 Million USD | 45.15% |
| 2002 Q1 | -997 Thousand USD | 88.18% |
| 2002 Q2 | -3.9 Million USD | -292.08% |
| 2002 FY | -17.15 Million USD | -15.67% |
| 2002 Q4 | -10.1 Million USD | -371.46% |
| 2001 Q3 | -1.99 Million USD | 52.33% |
| 2001 Q1 | -230 Thousand USD | 80.71% |
| 2001 Q2 | -4.17 Million USD | -1716.09% |
| 2001 FY | -14.83 Million USD | 21.53% |
| 2001 Q4 | -8.43 Million USD | -323.71% |
| 2000 Q3 | 541.53 Thousand USD | 102.92% |
| 2000 Q4 | -1.19 Million USD | -320.23% |
| 2000 FY | -18.9 Million USD | -959.16% |
| 2000 Q2 | -18.51 Million USD | -7125.01% |
| 2000 Q1 | 263.54 Thousand USD | -12.15% |
| 1999 Q3 | 500 Thousand USD | -28.57% |
| 1999 FY | 2.2 Million USD | -8.33% |
| 1999 Q4 | 300 Thousand USD | -40.0% |
| 1999 Q2 | 700 Thousand USD | 0.0% |
| 1999 Q1 | 700 Thousand USD | 40.0% |
| 1998 Q1 | 1.7 Million USD | 6.25% |
| 1998 FY | 2.4 Million USD | -67.57% |
| 1998 Q4 | 500 Thousand USD | 138.46% |
| 1998 Q3 | -1.3 Million USD | -186.67% |
| 1998 Q2 | 1.5 Million USD | -11.76% |
| 1997 Q3 | 2.1 Million USD | 5.0% |
| 1997 Q4 | 1.6 Million USD | -23.81% |
| 1997 Q2 | 2 Million USD | 17.65% |
| 1997 FY | 7.4 Million USD | 7.25% |
| 1997 Q1 | 1.7 Million USD | -10.53% |
| 1996 FY | 6.9 Million USD | -8.0% |
| 1996 Q4 | 1.9 Million USD | 5.56% |
| 1996 Q3 | 1.8 Million USD | 5.88% |
| 1996 Q2 | 1.7 Million USD | 13.33% |
| 1996 Q1 | 1.5 Million USD | -25.0% |
| 1995 Q2 | 1.8 Million USD | 12.5% |
| 1995 FY | 7.5 Million USD | -9.64% |
| 1995 Q4 | 2 Million USD | -4.76% |
| 1995 Q3 | 2.1 Million USD | 16.67% |
| 1995 Q1 | 1.6 Million USD | -61.9% |
| 1994 FY | 8.3 Million USD | 232.0% |
| 1994 Q1 | 1.1 Million USD | 22.22% |
| 1994 Q2 | 1.3 Million USD | 18.18% |
| 1994 Q3 | 1.7 Million USD | 30.77% |
| 1994 Q4 | 4.2 Million USD | 147.06% |
| 1993 Q3 | 600 Thousand USD | 0.0% |
| 1993 Q4 | 900 Thousand USD | 50.0% |
| 1993 Q2 | 600 Thousand USD | 50.0% |
| 1993 Q1 | 400 Thousand USD | 116.0% |
| 1993 FY | 2.5 Million USD | 149.02% |
| 1992 Q1 | 900 Thousand USD | 0.0% |
| 1992 Q4 | -2.5 Million USD | -38.89% |
| 1992 FY | -5.1 Million USD | 54.87% |
| 1992 Q3 | -1.8 Million USD | -12.5% |
| 1992 Q2 | -1.6 Million USD | -277.78% |
| 1991 Q4 | - USD | 0.0% |
| 1991 Q1 | -1.4 Million USD | 0.0% |
| 1991 Q2 | - USD | 100.0% |
| 1991 FY | -11.3 Million USD | -422.86% |
| 1991 Q3 | - USD | 0.0% |
| 1990 FY | 3.5 Million USD | 179.55% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 FY | -4.4 Million USD | -15.79% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 133.711% |
| AngioDynamics, Inc. | -184.34 Million USD | 111.58% |
| AtriCure, Inc. | -30.43 Million USD | 170.133% |
| Avinger, Inc. | -18.32 Million USD | 216.523% |
| Azenta, Inc. | -14.25 Million USD | 249.73% |
| BioLife Solutions, Inc. | -66.42 Million USD | 132.136% |
| The Cooper Companies, Inc. | 294.2 Million USD | 92.744% |
| Daxor Corporation | 280.64 Thousand USD | -7506.542% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 240.459% |
| Femasys Inc. | -14.24 Million USD | 249.834% |
| GlucoTrack, Inc. | -7.09 Million USD | 400.789% |
| Harvard Bioscience, Inc. | -3.41 Million USD | 725.095% |
| Hologic, Inc. | 789.5 Million USD | 97.296% |
| ICU Medical, Inc. | -29.65 Million USD | 171.984% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 98.813% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 255.352% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 29.092% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 420.361% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 420.361% |
| Masimo Corporation | 81.5 Million USD | 73.807% |
| Microbot Medical Inc. | -10.74 Million USD | 298.762% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | -83.624% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 77.389% |
| Nephros, Inc. | -1.57 Million USD | 1455.365% |
| NovoCure Limited | -207.04 Million USD | 110.31% |
| NEXGEL, Inc. | -3.15 Million USD | 776.18% |
| NEXGEL, Inc. | -3.15 Million USD | 776.18% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 122.513% |
| OraSure Technologies, Inc. | 53.65 Million USD | 60.214% |
| Pro-Dex, Inc. | 2.12 Million USD | -903.62% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 150.573% |
| Predictive Oncology Inc. | -13.98 Million USD | 252.653% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | 823.29% |
| QuidelOrtho Corporation | -10.1 Million USD | 311.356% |
| Repligen Corporation | 41.57 Million USD | 48.657% |
| Sanara MedTech Inc. | -4.3 Million USD | 596.073% |
| Sharps Technology, Inc. | -9.84 Million USD | 316.905% |
| Utah Medical Products, Inc. | 16.63 Million USD | -28.326% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 116.172% |
| Jin Medical International Ltd. | 2.87 Million USD | -641.671% |